The Department of Health reported that about 25 hospitals on the island have requested the acquisition of the drug Remdesivir, used to treat patients with Covid-19.
“Since the beginning of the pandemic, the federal government has allocated donated supplies of Remdesivir to states and territories, including Puerto Rico. However, this process transitioned to its acquisition through the open market ”, said the Secretary of Health, Lorenzo González Feliciano.
For this reason, the agency has begun an orientation process for hospital facility managers and CEOs regarding the commercial acquisition of the antiviral.
The agency explained that the states and territories will receive an allocation of supplies that hospitals can buy through the intermediary designated by the Gilead company, manufacturer of the drug.
This weekly allocation will be based on the hospitals reporting to the health departments the variables requested by the federal government, which include the number of hospitalized patients, hospitalized with Covid-19, intensive care, with a ventilator, among others.
Jessica Cabrera, director of the Bureau of Biosafety of the Department of Health, indicated that the orientation process began on August 14.
“The current supply of donated medicine is 378 vials and it is a contingency reserve to maintain the continuity of treatment for Covid-19 patients. This measure contemplates the possibility that an individual requires the start of treatment immediately and the acquisition process has not been completed under the new established procedure, ”added Cabrera.
Salud has held meetings with insurers and hospitals so that said treatment is provided to all patients who meet medical criteria, free of charge.
During the period of allocation by the federal government, Salud received 113 boxes of Remdesivir. This allocation is equivalent to a total amount of 4,520 vials, which have been distributed to 39 hospitals.